Latest revenue
$162.1M
as of 2026-03-31
Latest net income
$-7.0M
as of 2026-03-31
Net margin
-4.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $2.68B
- Enterprise value
- $2.68B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $85.25
- 52-wk low
- $38.51
- Beta
- —
- Shares out
- 43.0M
5-year trend
About TARS
Business description and risk factors will appear here once TARS's latest filing is fully ingested.
Profitability
Operating margin
-15.7%
76.1%Net margin
-14.7%
76.7%Return on equity
-19.3%
67.0%Return on assets
-11.8%
61.5%Leverage
Debt / equity
0.64×
30.3%Long-term debt / equity
0.21×
42.2%Debt / assets
38.9%
18.5%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $162.1M | +106.9% | $-7.0M | +72.3% | -4.3% |
Q4 2025 2025-12-31 | $151.7M | +128.4% | $-8.4M | +63.8% | -5.5% |
Q3 2025 2025-09-30 | $118.7M | +146.7% | $-12.6M | +46.3% | -10.6% |
Q2 2025 2025-06-30 | $102.7M | +151.5% | $-20.3M | +38.9% | -19.8% |
Q1 2025 2025-03-31 | $78.3M | +183.7% | $-25.1M | +29.7% | -32.1% |
Q4 2024 2024-12-31 | $66.4M | — | $-23.1M | — | -34.8% |
Q3 2024 2024-09-30 | $48.1M | +2471.8% | $-23.4M | +40.2% | -48.7% |
Q2 2024 2024-06-30 | $40.8M | — | $-33.3M | -5.9% | -81.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Biological Products, (No Diagnostic Substances) · SIC 2836
Your notes
Keep private notes on TARS — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$15.8M
Net activity
−$15.8M
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns TARS
Institutional value
$1.05B
Total shares held
15.0M
Distinct holders
138
-106 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.6M | $249.2M | -237.9K (-6.3%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $123.5M | — | New |
| 3 | JENNISON ASSOCIATES LLC | 1.7M | $120.1M | -517.9K (-23.2%) | Trimmed |
| 4 | Assenagon Asset Management S.A. | 1.3M | $89.8M | +152.5K (+13.5%) | Added |
| 5 | Invesco Ltd. | 742.5K | $52.1M | -269.9K (-26.7%) | Trimmed |
| 6 | Clearbridge Investments, LLC | 545.4K | $38.3M | +39.3K (+7.8%) | Added |
| 7 | TimesSquare Capital Management, LLC | 388.6K | $27.3M | +56.1K (+16.9%) | Added |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 335.9K | $23.6M | — | New |
| 9 | FRANKLIN RESOURCES INC | 333.7K | $23.4M | -3.3K (-1.0%) | Trimmed |
| 10 | Ensign Peak Advisors, Inc | 333.0K | $23.4M | -141.1K (-29.8%) | Trimmed |
| 11 | Nuveen, LLC | 315.3K | $22.1M | -7.2K (-2.2%) | Trimmed |
| 12 | Artisan Partners Limited Partnership | 307.3K | $21.6M | -129.3K (-29.6%) | Trimmed |
| 13 | BNP PARIBAS FINANCIAL MARKETS | 303.5K | $21.3M | -52.6K (-14.8%) | Trimmed |
| 14 | VANGUARD FIDUCIARY TRUST CO | 272.7K | $19.1M | — | New |
| 15 | M&G PLC | 166.4K | $11.6M | — | New |
| 16 | Russell Investments Group, Ltd. | 145.9K | $10.2M | -7.8K (-5.1%) | Trimmed |
| 17 | Allspring Global Investments Holdings, LLC | 131.6K | $9.2M | +1.2K (+0.9%) | Added |
| 18 | FIRST TRUST ADVISORS LP | 122.9K | $8.6M | +11.1K (+10.0%) | Added |
| 19 | DEUTSCHE BANK AG\ | 121.9K | $8.5M | +3.6K (+3.1%) | Added |
| 20 | Jefferies Financial Group Inc. | 118.8K | $8.3M | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once TARS's latest filing finishes processing.